As required by law, the independent federal agency that advises Congress on Medicare payment issues has transmitted its annual report to Congress with its observations, analysis, and policy recommendations.

- hospital short-stay policy
- payment policies for Part B drugs
- value-based incentives for Part B drugs
- polypharmacy and opioid use
- risk-sharing in Part D
- synchronizing policy across Medicare’s various payment models
- next steps in measuring quality
- the next generation of Medicare beneficiaries
Find a fact sheet on the MedPAC report here and the complete report itself here.

